ALLO-329 clinical trials

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

This study looks at a new treatment called ALLO-329 for serious autoimmune diseases like lupus and scleroderma. It's the first time this treatment is being used in people. Doctors want to see if it's safe, how well people tolerate it, and if it shows early signs of helping patients get better.